Phase III trial results of the R21/Matrix-M vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax's Matrix-M adjuvant, has confirmed high efficacy and supported regulatory approvals ...
Feb 2, 2024
0
32
Cameroon on Monday launched the first malaria vaccination program to be offered nationwide and as a matter of routine, in a step the WHO has described as "historic".
Jan 22, 2024
0
0
Cameroon will be the first country to routinely give children a new malaria vaccine as the shots are rolled out in Africa.
Jan 22, 2024
0
0
Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers ...
Jan 18, 2024
0
7
Though malaria has been eliminated in several countries, the mosquito-borne disease remains a major public health concern in sub-Saharan Africa. Mozambique has the fourth-highest prevalence of malaria in the region and is ...
Jan 17, 2024
0
2
Researchers in the U.S. and Uganda have developed tools that can detect the slightest traces of malaria in people who harbor the disease but do not show signs of sickness.
Jan 16, 2024
0
36
Benin has received its first doses of a vaccine for malaria, the leading cause of infant mortality in the country, and will begin administering them soon, officials said late on Monday.
Jan 16, 2024
0
0
In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of MAMAH, a clinical trial coordinated by the Barcelona Institute ...
Jan 12, 2024
1
37
A new study led by Menzies School of Health Research has provided further insight into the cost-effectiveness of a new malaria medication, tafenoquine, to treat vivax malaria.
Jan 11, 2024
0
51
For the first time in 20 years, locally transmitted cases of malaria have been reported in the U.S.
Dec 20, 2023
0
0
